MIT study finds global cancer risk from burning organic matter comes from unregulated chemicals

Former NCI official’s nonprofit seeks to tell the stories of cancer patients
Patient Action for Cancer Research aims to show impact of federal research

Chris Biggar, a 34-year-old from Ohio, had just landed his dream job working in R&D when he was diagnosed with stage 4 colon cancer.

October 03, 2025

Vol.51 No.36

By Sara Willa Ernst

NCI

Anthony Letai sworn in as 18th NCI director

Anthony G. Letai, accompanied by his wife Jean, was sworn in by HHS Secretary Kennedy as the 18th NCI Director on Sept. 29.Anthony G. Letai, a physician-scientist at Harvard Medical School and Dana-Farber Cancer Institute, has been officially named the 18th director of the National Cancer Institute.

October 03, 2025

Vol.51 No.36

By Claire Marie Porter

Capitol Hill

U.S. government shuts down
Impact on NCI uncertain as administration threatens more RIFs

On Oct. 1, for the first time in six years, the U.S. government shut down after Congress was unable to reach a deal to fund federal agencies for Fiscal Year 2026.

October 03, 2025

Vol.51 No.36

By Claire Marie Porter

Guest Editorial

Sexual and gender minoritized cancer patients deserve better

In recent months, federal policies have stripped away funding for research on sexual and gender minoritized (SGM) communities and blocked the collection of data related to gender.

October 03, 2025

Vol.51 No.36

By Don S. Dizon and Binay Shah

Guest Editorial

Seeding NCORPs with academically-focused oncologists can advance the national research agenda

Fiscal and strategic uncertainty abound at our leading academic medical centers. Job cuts to hospital staff (University of Southern California), research nurses (Vanderbilt) and librarians (Duke) are changing the landscape of our leading centers.

October 03, 2025

Vol.51 No.36

By Amarinthia (Amy) Curtis

The evolution of cellular immunotherapy: From transplant to CAR T cells

Nearly five decades ago, I joined City of Hope’s nascent bone marrow transplant (BMT) program, which focused on improving outcomes for patients with advanced leukemia.

October 03, 2025

Vol.51 No.36

By Stephen J. Forman

MIT study finds global cancer risk from burning organic matter comes from unregulated chemicals

YOU MAY BE INTERESTED IN

Former NCI official’s nonprofit seeks to tell the stories of cancer patients
Patient Action for Cancer Research aims to show impact of federal research

Anthony Letai sworn in as 18th NCI director

U.S. government shuts down
Impact on NCI uncertain as administration threatens more RIFs

Sexual and gender minoritized cancer patients deserve better

Seeding NCORPs with academically-focused oncologists can advance the national research agenda

The evolution of cellular immunotherapy: From transplant to CAR T cells

Renew today!

Subscriber content

Never miss an issue!

Login

MIT study finds global cancer risk from burning organic matter comes from unregulated chemicals

YOU MAY BE INTERESTED IN

Former NCI official’s nonprofit seeks to tell the stories of cancer patientsPatient Action for Cancer Research aims to show impact of federal research

Anthony Letai sworn in as 18th NCI director

U.S. government shuts downImpact on NCI uncertain as administration threatens more RIFs

Sexual and gender minoritized cancer patients deserve better

Seeding NCORPs with academically-focused oncologists can advance the national research agenda

The evolution of cellular immunotherapy: From transplant to CAR T cells

Never miss an issue!

Login

Former NCI official’s nonprofit seeks to tell the stories of cancer patients
Patient Action for Cancer Research aims to show impact of federal research

U.S. government shuts down
Impact on NCI uncertain as administration threatens more RIFs